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Introduction. The aim of the presents study was to compare the 
level of knowledge about Human Papilloma Virus (HPV) in vac-
cinated and non-vaccinated girls and to highlight the reasons why 
non-vaccinated girls refuse vaccination.
Methods. A cross-sectional study was conducted from October 
2012 to June 2013 in Turin (Piemonte Region, Italy). Question-
naires were administered to girls attending secondary and high 
schools randomly selected. 
Results. A total of 576 were compiled. The principle sources of 
information were parents and health workers. The main reported 
reasons for non-adherence to vaccination were the disagreement 
of the parents among the 11-12 years group (45.3%) and the lack 
of evidence on efficacy among the 18 years group (26.8%). By 
comparing the level of knowledge there was a statistically signifi-
cant difference between groups: vaccinated girls reported higher 
score than the unvaccinated group in several questions (p ≤ 0.05).
Conclusions. Our findings show a lack of information about HPV 
infection. Parents, school and health care workers have a central 
role in girl’s education and choices about HPV vaccination. The 
communication campaign for the prevention of cervical cancer 
must therefore be characterised by messages able to clarify and 
consolidate messages that may have been partially received or 
misunderstood.
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Introduction
Cervical cancer is the first cancer recognised by the 
World Health Organisation (WHO) as entirely due to 
the Human papillomavirus (HPV) infection. The avail-
ability of two vaccines, along with the screening poli-
cies, allows an intervention for the prevention of cervical 
cancer [1]. In 2006, the WHO decided that, based on the 
available evidence, girls aged 9-13 years are the primary 
target of HPV vaccination [2-4], while the females aged 
14-26 years are considered a secondary target.
The Italian health-care system is a regionally based na-
tional health service and each Region choses its vaccina-
tion strategy following the national recommendation that 
is to offer free HPV vaccination to 12-year-old females. 
However, some Regions offer vaccination to other age 
groups also, according to the WHO [1]. 
In particular, in Piemonte region (northwest of Italy), 
the vaccine is delivered by the Local Health Authori-
ties (Azienda Sanitaria Locale, ASL) to 11-12 years old 
girls, and, in addition, from 2008 to 2011, 16-year-old 
female subjects represented the secondary target. The 
vaccination service calls each girl with a personal letter. 
The aim of the vaccination programme in Italy was to 
achieve coverage with three doses of vaccine equal to 
95% within 5 years after the start of the immunisation 
programme. 
However, both in Italy and other Countries, compliance 
were less than expected [3, 4]. The Department of Epi-
demiology of Infectious Diseases of the National Cen-
tre of Epidemiology Surveillance and Health Promotion 
(CNESPS) collects data twice per year regarding vac-
cination coverage according to Region, birth cohort and 
number of doses administered. For the birth cohorts in 
1997-1998-1999, the document contains data with na-
tional coverage, updated on 30/06/2013, which amount 
to the following average values: 73% were vaccinated 
with at least 1 dose, 70% with at least 2 doses, and 67% 
with at least 3 doses [5]. In Piemonte region, the aver-
age coverage data for the three cohorts were slightly 
lower than the national average: 65.5% for the first dose, 
66.8% for the second and 53.6% for the third dose. The 
vaccination rate for the secondary target does not dif-
fer greatly, reaching 61.6% in 2011 in the case of the 
Piedmont region, with different values across the ASL 
ranging from 46.4% to 75.7%  [6]. Many studies have 
investigated the reasons associated with the low accept-
ance of HPV vaccination [7-13] such as: the availability of 
health care professionals to advise patients (the regarding 
to vaccination) [14], the will and the level of information 
of the parents [15, 16], the willingness of adolescents and 
young adults to receive the vaccination  [17-19], and the 
awareness and knowledge of this infection [20, 21]. Some 
studies show low levels of knowledge about HPV and 
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cervical cancer in women, others indicate that knowledge 
among young male subjects is even lower [3, 22-24]. A low 
level of knowledge about HPV is also noticed among pae-
diatricians and General Practitioner’s (GPs) [25-28]. Stud-
ies show a significant desire for information [4, 18, 23], 
particularly among parents [20, 29, 30]. It is also demon-
strated that where awareness campaigns are conducted 
the knowledge and attitudes of young people have im-
proved [13, 31-35]. Several studies were carried out in 
Italy on this topic. Among Italian women, partial infor-
mation is widespread regarding both HPV and vaccina-
tion [36]. The main source of information about HPV is 
represented by the mass media, while the role of health 
professionals is much less significant [37, 38]. Assess-
ments about the reasons for this less-than-enthusiastic 
reception are in progress, in an attempt to identify the 
communication errors that might have caused it. There 
are still few studies on the target population [39-44]. It 
seemed useful, therefore, to focus attention on the in-
formation provided and the ability to properly train the 
adolescent population to highlight the possible need for 
additional information. The aim of this study is to in-
vestigate the knowledge about HPV infection and vac-
cination among girls aged 11-12 years and aged 18-19 
years, highlighting the reasons that led to non-adherence 
to vaccination.
Methods
A cross-sectional study was conducted among a conven-
ience sample of girls attending three secondary and two 
high schools in Turin hinterland.
The main reason for this choice is that schools are the 
suitable place to catch up both vaccinated and non-
vaccinated girls. Questionnaires were realized based 
on literature information and tested in a small group of 
students (18 subjects). Subsequently, the questionnaires 
were administered in the schools by teachers assisted by 
several public health doctors between October 2012 and 
June 2013.
Subjects born in the years 1999-2000-2001, who were 
being convened at the time of the research, were chosen. 
The questionnaires were therefore distributed, with the 
same procedure mentioned above, to girls aged 18 who 
had been called for the vaccination when they were 15 
years old as secondary target population.
The questionnaire
It was composed by multiple choices 11 questions for 
younger girls and by 18 questions for the older girls. 
The first part investigated the vaccination status (vacci-
nated vs. non-vaccinated), the presence and the nature 
of the sources of information. In the second part of the 
questionnaire, the knowledge about the disease and the 
possibility of its prevention, the acceptance of the im-
munisation, and the need for further informative oppor-
tunities were investigated. Furthermore we added more 
questions for the older girls regarding modes of trans-
mission and HPV-related diseases. Each question had 
“yes”, “no” and “don’t know” as possible answer.
A written consent to fill in the questionnaires was asked 
for to underage girls’ parents. We received the approval 
from the director and the internal committee of each 
school. Participation was voluntary, anonymous and 
without compensation.
Statistical analysis
Descriptive statistics were reported as frequencies and 
percentages for categorical variables. Comparisons 
of frequencies were performed using two-tailed chi-
squared test and Fisher’s exact test. Crude odds ratios 
(ORs) with 95% Confidence Intervals (95%CI) were 
calculated to assess the association between the level of 
knowledge in different groups. The data were processed 
using the StataMP13 statistical software (Stata Corp., 
College Station, TX, 2013).
Results
Sample characteristics 
A total of 620 questionnaires were delivered to the girls, 
and, of these, 574 were returned (92.6%); 307 (53.6%) 
girls were unvaccinated, and 267 (46.4%) were vacci-
nated. Among these, 350 questionnaires were distributed 
in three middle schools, of which 327 were completed 
(93% of the sample); 128 girls had already been vac-
cinated (39% of the sample) (Group1), and 199 (60,8%) 
were not (Group 2); we included in this group, girls who 
were not already vaccinated, but called for the vaccina-
tion and inclined to do it (as indicated in the footstep 
note of the questionnaire by the girls); this is the reason 
why the coverage rate in this population appears lower 
than general population. 
The other 270 questionnaires were distributed in two 
high schools, of which 247 (92% of the sample) were 
returned. A total of 139 girls were vaccinated (56% of 
the sample) (Group3), and 108 were not (43.7% of the 
sample) (Group 4). 
Results of first part of the questionnaire
First part of the questionnaire showed that in Group 2, 
76.8% of the girls stated that they have heard about HPV 
infection and know that a vaccine exists. In Group 4, 
93.5% of the girls know HPV infection and 87% about 
HP vaccination.
We also asked to Group 2 and Group 4 what was the rea-
son for non-adherence to vaccination (Fig. 1), in Group2 
girls who refused the vaccination, the main reason was 
disagreement of parents (45.3%) followed by shortage 
of information (25%), the non-mandatory nature of the 
vaccine (15.6%) and other reasons (14.1%). In Group 
4, the main reason for non-adherence was the lack of 
information about vaccines (26.8%) followed by the 
non-mandatory nature (23.1%) and the disagreement 
of parents (19.4%). Other reasons together represented 
31.5% of answers. 
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The questionnaire of the vaccinated girls (Group 1 
and Group 3) investigated if they received explanation 
about HPV vaccination and from whom. In total, 82% 
of Group1 girls claimed to have received an explanation 
of the vaccine they had received during the visit and the 
reason why they were vaccinated, but 31% stated that 
they had yet to satisfy their curiosity about HPV infec-
tion and its vaccination. The majority of the girls claimed 
to have received information from their parents (70.3%); 
health care professionals of the Vaccination Service and 
paediatricians followed in a much smaller percentage, 
while gynaecologists, educators, the Internet, friends, 
advertising posters and flyers were marginal sources of 
information (Fig. 2).
In Group 3 72.2% of these girls received an explanation 
of what they received; 58% expressed some remaining 
curiosity. The majority of the girls claimed to have re-
ceived information from their parents, their paediatri-
cian/family doctor, and health care professionals of the 
Vaccination Service; a lower percentage (12-15%) re-
ceived information from their friends, gynaecologist, the 
mass media, posters/flyers or the Internet or at school. 
Other sources were considered marginal (Fig. 2).
Results of the second part  
of the questionnaire
In the second part of the questionnaire, we investigated 
the level of knowledge about HPV infection and vacci-
nation and then we compared the correct answers from 
vaccinated and non-vaccinated groups. This question-
naire part was constructed differently based on age, with 
more questions about transmission for the 18 years old 
group, for this reason we compared the groups divided 
for age.
Group 1: Already vaccinated 11 - 12 year olds, 31% an-
swered “yes” when we asked if HPV 
Infection is frequent and 23% stated that men could 
not be infected by HPV; only 38% knew that a person 
could be infected and aware of it. Data are presented 
in Table I.
Furthermore, 7% of the girls considered themselves to 
be at risk of contracting the infection in the future, and 
38.2% did not answer the question; 77.3% stated that 
it would be useful to discuss these subjects at school.
Group 2: 11-12 year olds unvaccinated due to rejection 
or waiting for the call, 65% of the girls stated they do 
not know whether HPV infection is frequent, 26% stated 
that men can be infected by HPV, and 42.2% knew that a 
person could be infected and be unaware of it. 12.5% of 
the girls believed they are at risk of becoming infected in 
the future, while 61.8% did not know the answer to the 
question; 71.8% stated that it would be useful to discuss 
these subjects at school.
The answers of these two groups are also compared in 
Table I, which shows that there were statistically sig-
nificant differences between the frequencies of two 
of the statement: HPV infection is frequent (OR 1.75; 
CI(95%): 1.05-2.92) and HPV infection can cause cervi-
cal cancer (OR 2.65 CI(95%): 1.62-4.45), with higher 
correct response in the vaccinated group (Group 1).
Group 3: 18 years old, vaccinated
In total, 56% of the girls knew whether HPV infection is 
frequent, 93% did not know whether HPV caused geni-
tal warts, 27.8% did not know whether the male gender 
Fig. 1. reasons for non-adherence in group 2 and group 4.
* Other: the lack of confidence in a new vaccine, the vaccine does not protect against every type of hpv, fear of the still unknown side 
effects of this vaccine. The vaccine does not provide long-lasting coverage. The information received was not convincing. It has been dis-
couraged by own doctor/gynaecologist. The vaccine is still experimental.
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can be infected, and 47% thought that wearing a con-
dom is sufficient to avoid contracting the infection. A 
percentage of 69% knew the mode of transmission of 
HPV, and 15% were not aware that HPV infection could 
cause cervical cancer. Table II summarises these data.
Group 4: 18 years old, non-vaccinated
In the non-vaccinated group, 24% of the sample knew 
the HPV infection is frequent, 7% knew that genital 
warts are caused by HPV, 21% did not know whether 
the male gender could be infected, and 26% said that 
wearing a condom is sufficient to avoid contracting the 
infection. A percentage of 47% knew that sexual inter-
course are a possible way of HPV transmission, and 
53% were aware that HPV infection could cause cer-
vical cancer.
Comparing the answers from the two groups, as 
shown in table 2, a statistically significant difference 
was observed for the questions about the prevalence 
(OR 1.38 CI(95%): 1.04-2.92) and the consequences 
of the HPV infection (OR 1.10; CI(95%): 1.01-3.92); 
indicated that be vaccinated and receiving explanation 
about vaccination is related with higher knowledge 
about HPV. 
Finally, the last question asked to the girls if they thought 
it would be useful to discuss these subjects at school, the 
majority of the girls (96%) answered yes to this ques-
tion.
Discussion
The present study aimed to investigate the knowledge 
about HPV infection and vaccine among young girls in 
Italy (Piemonte Region). Interestingly, the answers to 
Fig. 2. Sources of information in group 1 and group 3.
Tab. I. Knowledge in group 1 (11-12 years old vaccinated girls) and group 2(11-12 years old unvaccinated girls) (the reference group Or = 1 is 
the one of unvaccinated girls).
 
 
Correct answer  
Group 1 
N = 128)
Group 2
(N = 199)
 
 
OR
CI(95%)
hpv infection is frequent 31% 21% p = 0.03
Or =1.75
(1.05-2.92)
hpv infection can cause cervical cancer  76% 54% p < 0.001
Or =2.69
(1.62-4.45)
men cannot be infected by hpv 23% 26% p = 0.654
Or =1.78
(0.52-1.49)
A person may be infected by hpv and not 
be aware of it 
38% 42% p = 0.5726
Or =0.87
(0.55-1.38)
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the questionnaires showed some elements that can im-
prove the efficacy of a vaccination campaign. The main 
source of information is represented by the parents, who, 
in most cases, are also those that bring girls to the vac-
cination centre; even in this case, the family is one of 
the most important source of information, in agreement 
with previous studies [8, 9, 30, 45]. Since the majority 
of the respondents recognizes the informational role of 
parents, it could be important to support and improve 
the knowledge of this source of information; conversely, 
health care workers appeared to have a slightly lower 
frequency as information providers and it could be of 
interest to understand why.
The majority of the girls stated that it would be useful 
to discuss HPV vaccination at school, that could play 
an important preventive role, by providing information 
about the different risky behaviours: in this sense, spe-
cific interventions may also be useful to clarify the con-
tradictory messages that have spread, which have a nega-
tive impact on adherence to vaccination campaigns [23]. 
Interestingly, it should be stressed that in Countries such 
as the UK, an effective, comprehensive and organised 
school communication campaign has allowed us to 
reach coverage greater than 90% [23]. 
The majority of respondents claimed to have received 
explanations about the vaccination and its justifications; 
however, when knowledge about HPV infection and its 
mode of transmission were investigated, there was a 
statistically significant difference between the levels of 
knowledge of the two groups, which was higher in the 
group of vaccinated girls. The knowledge in the group 
of 18 year olds, questioned even on the “most sensitive” 
themes, showed a lack of information about the infec-
tion, its consequences, and modes of transmission and 
prevention; being vaccinated improve significantly the 
level of knowledge for few topics. It may therefore be 
important for health professionals and parents to be sup-
ported and to develop communication skills about sexu-
ality [4, 17].
In the group of unvaccinated girls, both minors and 
adults, the lack of parental consent and of clarity of the 
information about the safety and efficacy of vaccination 
emerged as the main reasons behind this choice. One 
item worth noting is represented by the considerations 
of the involved teachers, who reported that the question-
naire was a first opportunity to address important issues 
to which little time and attention are usually devoted; at 
the same time the majority of the scholar said that could 
be interesting to discuss these topics at school; these 
findings are important to emphasize the role that school 
could have in sexual and health education.
Limitations of the study are the use of a convenience 
sampling, the peer influence of opinions between class-
mates and the issue of the reliability of the answers. Fur-
thermore, the survey was conducted in the Torino area 
only, rather than opening up to different contexts, which 
could produce different results.
Conclusions
In conclusion, the proposed prevention model is based 
on a twofold assertion: first, the centrality of the ado-
lescent and his/her action in his/her own health choices 
and, second, the strong educational role of the adult, the 
school and health care professional. The communica-
tion campaign for the prevention of cervical cancer must 
therefore be characterised by messages able to reach 
new cohorts every year in order to clarify and consoli-
date messages that may have been partially received or 
Tab. II. Knowledge in group 3 (18 years old vaccinated girls) and group 4 (18 years old unvaccinated girls) (the reference group Or = 1 is the 
one of unvaccinated girls).
 
 
Correct answer
 
 
Group 3
(N = 139)
Group 4
(N = 108)
OR
CI(95%)
hpv infection is frequent 56% 24% p = 0.001
Or = 1.38
(1.04-2.92)
hpv can be transmitted through sexual 
intercourse
69% 47% p = 0.22
Or = 0.39
(0.81-2.37)
hpv infection can cause cervical cancer 85% 53% p = 0.03
Or = 1.10
(1.02-3.92)
genital warts are caused by hpv 7% 7% p = 0.68
Or = 0.27
(0.4-4.0)
men cannot be infected by hpv 28% 21% p = 0.75
Or = 0.48
(0.52-1.60)
It’s sufficient to wear a condom to avoid 
contracting the infection
47% 26% p = 0.28
Or = 0.93
(0.78-2.22)
A person may be infected by hpv and not 
be aware of it
75% 51% p = 0.37
Or = 0.29
(0.73-2.26)
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misunderstood; particularly the information about long 
term efficacy, the appropriate age of administration and 
safety of both vaccines.
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